Haixin Co., Ltd. (600851.SH) subsidiary's vitamin B6 injection passed the generic drug consistency evaluation

Zhitongcaijing · 2d ago

Zhitong Finance App News, Haixin Co., Ltd. (600851.SH) issued an announcement. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. (Gannan Haixin for short), the holding subsidiary of the company, recently obtained the “Drug Supplement Application Approval Notice” for the chemical “Vitamin B6 Injection” approved by the State Drug Administration. The drug passed the consistent evaluation of generic drug quality and efficacy.

Through consistent evaluation of the quality and efficacy of generic drugs, vitamin B6 injections helped enhance the market competitiveness of Haixin products in Gannan, and accumulated work experience for subsequent new drug research and development.